CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Commitment and Contingencies (Details)

Note 12 - Commitment and Contingencies (Details)							3 Months Ended		12 Months Ended
Note 12 - Commitment and Contingencies (Details)	Aug. 23, 2017 USD ($)	Mar. 01, 2017 USD ($)	Jul. 20, 2016 USD ($)	Aug. 01, 2015 USD ($)	Apr. 17, 2015 ft²	Oct. 01, 2014 USD ($)	Aug. 31, 2017 USD ($)	Aug. 31, 2016 USD ($)	May 31, 2016 USD ($) shares	May 31, 2017 USD ($)
Note 12 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision							$ 10,000
Debt Conversion, Original Debt, Amount							62,500	$ 250,000
Employee-related Liabilities, Current							32,752			$ 34,987
Chief Executive Officer [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term						5 years
Officers' Compensation						$ 150,000			$ 150,000
Deferred Compensation Arrangement with Individual, Description						performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description						annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employee-related Liabilities, Current							12,500			37,500
Chief Executive Officer [Member] \| Convertible Debt [Member] \| Unpaid Accrued Salary Converted to Convertible Note [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 62,500	$ 112,500	$ 250,000				62,500
Chief Operating Officer [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term				5 years
Officers' Compensation				$ 150,000
Deferred Compensation Arrangement with Individual, Description				performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description				annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employee-related Liabilities, Current							25,000			0
Chief Operating Officer [Member] \| One Time Signing Bonus [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares									250,000
Allocated Share-based Compensation Expense									$ 327,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period									1 year
Former Officer [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Employee-related Liabilities, Current							16,250			$ 16,250
Building [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Area of Real Estate Property (in Square Feet) \| ft²					14,392
Lessee, Operating Lease, Term of Contract					72 months
Lessee, Operating Lease, Renewal Term					10 years
Deposits [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision							50,000
Rent Expense [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision							15,699
Remaining Amounts Due Under Lease [Member]
Note 12 - Commitment and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision							$ 30,000